Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

Share Price is delayed by 15 minutes
Get Live Data
41.12    -1.44 (-3.38%)
Bid:
41.06
Ask:
43.48
Spread: 2.42 (5.894%)
Market Cap: £416.42m
AML Live PriceLast checked at - London Stock Exchange

Intraday Aston Martin Lagonda Share Chart

FTSE 250 movers: Saga sinks, Indivior increases

8 Apr 2019 15:57

(Sharecast News) - London's FTSE 250 index was 0.09% lower at 19,520.63 in afternoon trade on Monday, as Saga dragged the index lower.The over-50s holidays and insurance specialist was hit by a downgrade to 'neutral' from 'buy' at UBS, with the stock's target price also slashed from 150p to 65p, following a profit warning, dividend cut and strategy change last week. "Since its IPO, Saga has now profit warned twice and removed its medium term earnings growth guidance. We find further execution risks around the new strategy, which we expect to weigh on the PE multiple," said the note. Aston Martin Lagonda was knocked lower by a downgrade to 'hold' from 'buy' at Deutsche Bank, with its target price cut from 2,000p to 1,000p in anticipation of volatility in auto markets and Brexit-related uncertainty weighing on sales momentum. "In line with the previous company communication, we have been of the view that Aston Martin would be less exposed to end-market volatility, but we revise our view, on the back of a slowdown in Aston's key markets, Germany and the UK, weighing on sales momentum," said Deutsche Bank analysts. Anti opioid addiction drug manufacturer Indivior advanced after disclosing that a clinical study had shown that patients with moderate to severe opioid-use disorder may benefit from a higher maintenance dose of its Sublocade monthly injection for the treatment of moderate-to-severe opioid use disorder. Bakkavor climbed after chief executive Agust Gudmundsson said he expected an uplift in UK revenues as the ready meals maker begins to benefit from recently secured new business, while 888 Holdings was higher as it confirmed that it is seeking approval to repurchase 10% of its shares. Finally, Energean Oil and Gas gained as it announced the successful completion of drilling operations of the extended reach well EA-H3 at Epsilon. Market Movers FTSE 250 (MCX) 19,520.63 -0.09% FTSE 250 - Risers Indivior (INDV) 105.30p 6.19%Bakkavor Group (BAKK) 133.50p 5.45%Amigo Holdings (AMGO) 225.44p 3.89%888 Holdings (888) 161.50p 2.93%Ferrexpo (FXPO) 287.10p 2.54%Energean Oil & Gas (ENOG) 785.00p 2.21%Greencore Group (GNC) 208.10p 2.16%Premier Oil (PMO) 102.35p 2.09%Acacia Mining (ACA) 202.80p 2.06%Provident Financial (PFG) 510.20p 2.04% FTSE 250 - Fallers Saga (SAGA) 61.27p -7.86%Senior (SNR) 220.80p -5.64%Aston Martin Lagonda Global Holdings (AML) 958.42p -5.61%Kier Group (KIE) 343.79p -4.50%Royal Mail (RMG) 246.65p -3.08%Redrow (RDW) 628.70p -2.96%Dixons Carphone (DC.) 140.55p -2.26%Stagecoach Group (SGC) 136.20p -1.94%Mediclinic International (MDC) 315.20p -1.90%Just Group (JUST) 63.85p -1.77%
Date   Source Headline
4th Jun 20267:00 amRNSIssue of equity to satisfy share awards
15th May 20267:00 amRNSIssue of equity to satisfy employee share awards
6th May 202612:51 pmRNSVoting results of AGM 2026
29th Apr 20267:00 amRNSQ1 results for three months ended 31 March 2026
25th Mar 20269:53 amRNSAnnual Financial Report
9th Mar 202612:12 pmRNSResult of Meeting
25th Feb 20267:00 amRNSPreliminary Results FY2025
20th Feb 20267:00 amRNSNotice of GM and FY 2025 Trading Update
29th Oct 20257:00 amRNSQ3 results for the quarter ended 30 September 2025
6th Oct 20257:00 amRNSQ3 2025 Trading Update and revised outlook
10th Sep 202511:33 amRNSDirector/PDMR Shareholding
5th Sep 20257:00 amRNSIssue of equity to satisfy employee share awards
30th Jul 20257:00 amRNSInterim results
28th Jul 20254:33 pmRNSDirectorate Change
27th May 202510:13 amRNSDirector/PDMR Shareholding
27th May 202510:12 amRNSDirector/PDMR Shareholding
15th May 202510:38 amRNSHolding(s) in Company
13th May 20255:26 pmRNSHolding(s) in Company
13th May 202510:33 amRNSDirector/PDMR Shareholding
13th May 202510:31 amRNSDirector/PDMR Shareholding
13th May 202510:26 amRNSDirector/PDMR Shareholding
12th May 20255:53 pmRNSHolding(s) in Company
12th May 20251:13 pmRNSHolding(s) in Company
12th May 202512:52 pmRNSHolding(s) in Company
7th May 20252:45 pmRNSDirector/PDMR Shareholding
7th May 20251:15 pmRNSResult of General Meeting and issue of equity
7th May 20251:07 pmRNSVoting Result of AGM
30th Apr 20257:00 amRNS1st Quarter Results
17th Apr 20258:57 amRNSNotice of General Meeting
16th Apr 20253:20 pmRNSDirector Declaration
31st Mar 20255:11 pmRNSStatement regarding media comments
31st Mar 20257:00 amRNSProposed investment by Yew Tree Consortium
26th Mar 20259:24 amRNSAnnual Financial Report
26th Feb 20257:00 amRNSPreliminary results year ended 31 December 2024
25th Feb 202510:00 amRNSIndependent Non-executive Director appointment
7th Feb 20255:29 pmRNSHolding(s) in Company
13th Dec 20249:00 amRNSDirectorate Change
4th Dec 20244:00 pmRNSHolding(s) in Company
29th Nov 20244:15 pmRNSHolding(s) in Company
29th Nov 20241:01 pmRNSHolding(s) in Company
29th Nov 202412:46 pmRNSDirector/PDMR Shareholding Replacement
29th Nov 202412:18 pmRNSDirector/PDMR Shareholding
29th Nov 202412:17 pmRNSDirector/PDMR Shareholding
29th Nov 202412:11 pmRNSDirector/PDMR Shareholding
27th Nov 20247:00 amRNSResult of Equity Issue
26th Nov 20245:06 pmRNSIssue of Equity
26th Nov 20244:58 pmRNSIssue of Equity
6th Nov 202410:37 amRNSDirector/PDMR Shareholding
30th Oct 20247:00 amRNS3rd Quarter Results
30th Sep 20247:00 amRNSTrading Update and adjustment to FY 2024 guidance

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.